82 FR 19082 - Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest

INTERNATIONAL TRADE COMMISSION

Federal Register Volume 82, Issue 78 (April 25, 2017)

Page Range		19082-19083
FR Document		2017-08232

Notice is hereby given that the U.S. International Trade Commission has received a complaint entitled Certain Robotic Vacuum Cleaning Devices and Components Thereof Such as Spare Parts, DN 3216; the Commission is soliciting comments on any public interest issues raised by the complaint or complainant's filing pursuant to the Commission's Rules of Practice and Procedure.

Federal Register, Volume 82 Issue 78 (Tuesday, April 25, 2017)

[Federal Register Volume 82, Number 78 (Tuesday, April 25, 2017)]
[Notices]
[Pages 19082-19083]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-08232]



[[Page 19082]]

-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION


Notice of Receipt of Complaint; Solicitation of Comments Relating 
to the Public Interest

AGENCY: U.S. International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the U.S. International Trade 
Commission has received a complaint entitled Certain Robotic Vacuum 
Cleaning Devices and Components Thereof Such as Spare Parts, DN 3216; 
the Commission is soliciting comments on any public interest issues 
raised by the complaint or complainant's filing pursuant to the 
Commission's Rules of Practice and Procedure.

FOR FURTHER INFORMATION CONTACT: Lisa R. Barton, Secretary to the 
Commission, U.S. International Trade Commission, 500 E Street SW., 
Washington, DC 20436, telephone (202) 205-2000. The public version of 
the complaint can be accessed on the Commission's Electronic Document 
Information System (EDIS) at https://edis.usitc.gov, and will be 
available for inspection during official business hours (8:45 a.m. to 
5:15 p.m.) in the Office of the Secretary, U.S. International Trade 
Commission, 500 E Street SW., Washington, DC 20436, telephone (202) 
205-2000.
    General information concerning the Commission may also be obtained 
by accessing its Internet server at United States International Trade 
Commission (USITC) at https://www.usitc.gov. The public record for this 
investigation may be viewed on the Commission's Electronic Document 
Information System (EDIS) at https://edis.usitc.gov. Hearing-impaired 
persons are advised that information on this matter can be obtained by 
contacting the Commission's TDD terminal on (202) 205-1810.

SUPPLEMENTARY INFORMATION: The Commission has received a complaint and 
a submission pursuant to Sec.  210.8(b) of the Commission's Rules of 
Practice and Procedure filed on behalf of iRobot Corporation on April 
18, 2017. The complaint alleges violations of section 337 of the Tariff 
Act of 1930 (19 U.S.C. 1337) in the importation into the United States, 
the sale for importation, and the sale within the United States after 
importation of certain robotic vacuum cleaning devices and components 
thereof such as spare parts. The complaint names as respondents Bissell 
Homecare, Inc. of Grand Rapids, MI; Hoover Inc. of Glenwillow, OH; 
Royal Appliance Manufacturing Co., Inc. d/b/a TTI Floor Care North 
America, Inc. of Glenwillow, OH; Bobsweep, Inc. of Canada; Bobsweep USA 
of Henderson, NV; The Black & Decker Corporation of Towson, MD; Black 
and Decker (U.S.) Inc. of Towson, MD; Shenzhen ZhiYi Technology Co., 
Ltd. d/b/a iLife of China; Matsutek Enterprises Co., Ltd. of Taiwan; 
Suzhou Real Power Electric Appliance Co., Ltd. of China; and Shenzhen 
Silver Star Intelligent Technology Co., Ltd. of China. The complainant 
requests that the Commission issue a limited exclusion order, cease and 
desist orders and impose a bond upon respondents' alleged infringing 
articles during the 60-day Presidential review period pursuant to 19 
U.S.C. 1337(j).
    Proposed respondents, other interested parties, and members of the 
public are invited to file comments, not to exceed five (5) pages in 
length, inclusive of attachments, on any public interest issues raised 
by the complaint or Sec.  210.8(b) filing. Comments should address 
whether issuance of the relief specifically requested by the 
complainant in this investigation would affect the public health and 
welfare in the United States, competitive conditions in the United 
States economy, the production of like or directly competitive articles 
in the United States, or United States consumers.
    In particular, the Commission is interested in comments that:
    (i) Explain how the articles potentially subject to the requested 
remedial orders are used in the United States;
    (ii) identify any public health, safety, or welfare concerns in the 
United States relating to the requested remedial orders;
    (iii) identify like or directly competitive articles that 
complainant, its licensees, or third parties make in the United States 
which could replace the subject articles if they were to be excluded;
    (iv) indicate whether complainant, complainant's licensees, and/or 
third party suppliers have the capacity to replace the volume of 
articles potentially subject to the requested exclusion order and/or a 
cease and desist order within a commercially reasonable time; and
    (v) explain how the requested remedial orders would impact United 
States consumers.
    Written submissions must be filed no later than by close of 
business, eight calendar days after the date of publication of this 
notice in the Federal Register. There will be further opportunities for 
comment on the public interest after the issuance of any final initial 
determination in this investigation.
    Persons filing written submissions must file the original document 
electronically on or before the deadlines stated above and submit 8 
true paper copies to the Office of the Secretary by noon the next day 
pursuant to Sec.  210.4(f) of the Commission's Rules of Practice and 
Procedure (19 CFR 210.4(f)). Submissions should refer to the docket 
number (``Docket No. 3216'') in a prominent place on the cover page 
and/or the first page. (See Handbook for Electronic Filing Procedures, 
Electronic Filing Procedures \1\). Persons with questions regarding 
filing should contact the Secretary (202-205-2000).
---------------------------------------------------------------------------

    \1\ Handbook for Electronic Filing Procedures: https://www.usitc.gov/documents/handbook_on_filing_procedures.pdf.
---------------------------------------------------------------------------

    Any person desiring to submit a document to the Commission in 
confidence must request confidential treatment. All such requests 
should be directed to the Secretary to the Commission and must include 
a full statement of the reasons why the Commission should grant such 
treatment. See 19 CFR 201.6. Documents for which confidential treatment 
by the Commission is properly sought will be treated accordingly. All 
such requests should be directed to the Secretary to the Commission and 
must include a full statement of the reasons why the Commission should 
grant such treatment. See 19 CFR 201.6. Documents for which 
confidential treatment by the Commission is properly sought will be 
treated accordingly. All information, including confidential business 
information and documents for which confidential treatment is properly 
sought, submitted to the Commission for purposes of this Investigation 
may be disclosed to and used: (i) By the Commission, its employees and 
Offices, and contract personnel (a) for developing or maintaining the 
records of this or a related proceeding, or (b) in internal 
investigations, audits, reviews, and evaluations relating to the 
programs, personnel, and operations of the Commission including under 5 
U.S.C. Appendix 3; or (ii) by U.S. government employees and contract 
personnel \2\, solely for cybersecurity purposes. All nonconfidential 
written submissions will be available for public inspection at the 
Office of the Secretary and on EDIS.\3\
---------------------------------------------------------------------------

    \2\ All contract personnel will sign appropriate nondisclosure 
agreements.
    \3\ Electronic Document Information System (EDIS): https://edis.usitc.gov.

---------------------------------------------------------------------------

[[Page 19083]]

    This action is taken under the authority of section 337 of the 
Tariff Act of 1930, as amended (19 U.S.C. 1337), and of Sec. Sec.  
201.10 and 210.8(c) of the Commission's Rules of Practice and Procedure 
---------------------------------------------------------------------------
(19 CFR 201.10, 210.8(c)).

    By order of the Commission.

    Dated: April 18, 2017.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2017-08232 Filed 4-24-17; 8:45 am]
 BILLING CODE 7020-02-P

Federal Register / Vol. 82, No. 78 / Tuesday, April 25, 2017 / Notices 19083

This action is taken under the redelegated to the Assistant In accordance with 21 CFR
authority of section 337 of the Tariff Act Administrator of the DEA Diversion 1301.33(a), this is notice that on June 1,
of 1930, as amended (19 U.S.C. 1337), Control Division (‘‘Assistant 2016, Cedarburg Pharmaceuticals Inc., A
and of §§ 201.10 and 210.8(c) of the Administrator’’) pursuant to section 7 of Division of Albany Molecular Research
Commission’s Rules of Practice and 28 CFR part 0, appendix to subpart R. Inc. (AMRI), 870 Badger Circle, Grafton,
Procedure (19 CFR 201.10, 210.8(c)). In accordance with 21 CFR Wisconsin 53024 applied to be
By order of the Commission.
1301.34(a), this is notice that on registered as a bulk manufacturer of the
December 16, 2016, Janssen Ortho LLC, following basic classes of controlled
Dated: April 18, 2017.
State Road 933 DM 0.1 Mamey Ward, substances:
Lisa R. Barton, Gurabo, Puerto Rico 00778 applied to be
Secretary to the Commission. registered as an importer of tapentadol Drug
Controlled Substance Schedule
[FR Doc. 2017–08232 Filed 4–24–17; 8:45 am] (9780), a basic class of controlled Code
BILLING CODE 7020–02–P substance listed in schedule II.
The company plans to import an Marihuana ................... 7360 I
Tetrahydrocannabinols 7370 I
intermediate form of tapentadol (9780) Lisdexamfetamine ...... 1205 II
DEPARTMENT OF JUSTICE to bulk manufacture tapentadol for 4-Anilino-N-phenethyl- 8333 II
distribution to its customers. 4-piperidine (ANPP).
Drug Enforcement Administration Dated: April 18, 2017. Remifentanil ................ 9739 II
Louis J. Milione, Fentanyl ...................... 9801 II
[Docket No. DEA–392]
Assistant Administrator.
Importer of Controlled Substances The company plans to manufacture
[FR Doc. 2017–08345 Filed 4–24–17; 8:45 am]
Application: Janssen Ortho LLC the above-listed controlled substances
BILLING CODE 4410–09–P in bulk for distribution to its customers.
ACTION: Notice of application. In reference to drug codes 7360
marihuana, the company plans to bulk
DEPARTMENT OF JUSTICE
DATES: Registered bulk manufacturers of manufacture cannabidiol as a synthetic
the affected basic class, and applicants Drug Enforcement Administration intermediate. This controlled substance
therefore, may file written comments on will be further synthesized to bulk
or objections to the issuance of the [Docket No. DEA–392] manufacture a synthetic
proposed registration in accordance tetrahydrocannabinols 7370. No other
Bulk Manufacturer of Controlled
with 21 CFR 1301.34(a) on or before activity for this drug code is authorized
Substances Application: Cedarburg
May 25, 2017. Such persons may also for this registration.
Pharmaceuticals
file a written request for a hearing on Dated: April 18, 2017.
the application pursuant to 21 CFR ACTION: Notice of application. Louis J. Milione,
1301.43 on or before May 25, 2017. Assistant Administrator.
ADDRESSES: Written comments should DATES: Registered bulk manufacturers of
[FR Doc. 2017–08343 Filed 4–24–17; 8:45 am]
be sent to: Drug Enforcement the affected basic classes, and
BILLING CODE 4410–09–P
Administration, Attention: DEA Federal applicants therefore, may file written
Register Representative/DRW, 8701 comments on or objections to the
Morrissette Drive, Springfield, Virginia issuance of the proposed registration in
DEPARTMENT OF JUSTICE
22152. All requests for hearing must be accordance with 21 CFR 1301.33(a) on
sent to: Drug Enforcement or before June 26, 2017. Drug Enforcement Administration
Administration, Attn: Administrator, ADDRESSES: Written comments should
[Docket No. DEA–392]
8701 Morrissette Drive, Springfield, be sent to: Drug Enforcement
Virginia 22152. All requests for hearing Administration, Attention: DEA Federal Importer of Controlled Substances
should also be sent to: (1) Drug Register Representative/DRW, 8701 Application: Cambridge Isotope
Enforcement Administration, Attn: Morrissette Drive, Springfield, Virginia Laboratories
Hearing Clerk/LJ, 8701 Morrissette 22152.
Drive, Springfield, Virginia 22152; and SUPPLEMENTARY INFORMATION: The ACTION: Notice of application.
(2) Drug Enforcement Administration, Attorney General has delegated his
Attn: DEA Federal Register authority under the Controlled DATES: Registered bulk manufacturers of
Representative/DRW, 8701 Morrissette Substances Act to the Administrator of the affected basic classes, and
Drive, Springfield, Virginia 22152. the Drug Enforcement Administration applicants therefore, may file written
SUPPLEMENTARY INFORMATION: The (DEA), 28 CFR 0.100(b). Authority to comments on or objections to the
Attorney General has delegated his exercise all necessary functions with issuance of the proposed registration in
authority under the Controlled respect to the promulgation and accordance with 21 CFR 1301.34(a) on
Substances Act to the Administrator of implementation of 21 CFR part 1301, or before May 25, 2017. Such persons
the Drug Enforcement Administration incident to the registration of may also file a written request for a
(DEA), 28 CFR 0.100(b). Authority to manufacturers, distributors, dispensers, hearing on the application pursuant to
exercise all necessary functions with importers, and exporters of controlled 21 CFR 1301.43 on or before May 25,
asabaliauskas on DSK3SPTVN1PROD with NOTICES

respect to the promulgation and substances (other than final orders in 2017.
implementation of 21 CFR part 1301, connection with suspension, denial, or ADDRESSES: Written comments should
incident to the registration of revocation of registration) has been be sent to: Drug Enforcement
manufacturers, distributors, dispensers, redelegated to the Assistant Administration, Attention: DEA Federal
importers, and exporters of controlled Administrator of the DEA Diversion Register Representative/DRW, 8701
substances (other than final orders in Control Division (‘‘Assistant Morrissette Drive, Springfield, Virginia
connection with suspension, denial, or Administrator’’) pursuant to section 7 of 22152. All requests for hearing must be
revocation of registration) has been 28 CFR part 0, appendix to subpart R. sent to: Drug Enforcement

VerDate Sep<11>2014 17:42 Apr 24, 2017 Jkt 241001 PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 E:\FR\FM\25APN1.SGM 25APN1

Document Created: 2017-04-25 02:18:39
Document Modified: 2017-04-25 02:18:39

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice.
Contact		Lisa R. Barton, Secretary to the Commission, U.S. International Trade Commission, 500 E Street SW., Washington, DC 20436, telephone (202) 205-2000. The public version of the complaint can be accessed on the Commission's Electronic Document Information System (EDIS) at https://edis.usitc.gov, and will be available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW., Washington, DC 20436, telephone (202) 205-2000.
FR Citation		82 FR 19082